Respiratorius AB Sustainability Reports
Respiratorius AB is a biotechnology research company that develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and severe asthma. The company focuses on utilizing its proprietary technology platform to screen and optimize clinical candidates through early development stages.
Sector: Professional & technical services
Country: Sweden
Exchange: Nordic Growth Market
ISIN: SE0023314315
8 reports from 2005 to 2021